What are the risks and recovery expectations?

Common risks include cytokine release syndrome (CRS), which can cause fever, low blood pressure, and breathing difficulty, and neurotoxicity (ICANS) such as confusion or seizures. These are managed with supportive care and medications like tocilizumab. Other side effects include low blood counts and infections. Recovery typically takes 3–6 months, with gradual return to normal activities. Long-term monitoring for B-cell aplasia and infections is needed. Most patients require hospital stay during the initial 2–3 weeks post-infusion.